Composition
- Active ingredients
- EFAVIRENZ, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 400MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA213509.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Efavirenz, Emtricitabine and Tenofovir Alafenamide
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Mylan
- Status
- Tentative approval
- FDA approval
- 22 Mar 2024
- Application
- NDA213509-001